logo
In temples and churches, sensory rooms remove barriers for neurodivergent worshipers

In temples and churches, sensory rooms remove barriers for neurodivergent worshipers

MAPLEWOOD, N.J. (RNS) — From organ blasts and incense to forced hugs and hand shakes, for folks who struggle to process sensory input, houses of worship can quickly feel anything but holy.
That was the case for Lark Losardo's son Percy, who in 2017 began attending Catholic Mass with his family at age 7. Percy, who is autistic, was often overwhelmed by the Brooklyn church's open space, noise and crowds. At first, when he needed to move around or stim (engage in repetitive actions to self-regulate), he'd leave the service with a parent. Eventually, in part because of the barriers to attending as a family, they stopped coming altogether.
Then, in 2020, the Losardos moved to Maplewood, New Jersey. After watching online services at a nearby Catholic parish called St. Joseph's during the pandemic, Lark Losardo learned in 2024 that the parish was opening a sensory room equipped with regulation tools, including a weighted blanket, touch pillow, ear defenders and sound machine. Thanks to that room, today Percy is back in the pews, using the room to regroup whenever needed.
'It speaks volumes,' Lark Losardo told Religion News Service. 'Not everyone needs this space, but just having it there sends a very clear message.'
___
This content is written and produced by Religion News Service and distributed by The Associated Press. RNS and AP partner on some religion news content. RNS is solely responsible for this story.
___
Across the U.S., families like Percy's who once thought worship was off-limits are returning to faith communities thanks to a small but growing number of sensory rooms in religious settings. Located in underutilized classrooms, storage spaces and former nurseries, these rooms vary in size and appearance, but are all designed to offer a calm, predictable environment that can help with nervous system regulation. Disability advocates say the rooms signal that a community prioritizes the needs of neurodivergent and disabled members.
At St. Joseph's, the Rev. Jim Worth said the new sensory room, which opened in December, isa natural extension of the parish's faith values. To him, the room is evidence that inclusion — a principle Worth linked to Catholic social teaching — isn't just given lip service.
'When you put intentionality behind something, it makes a world of difference,' said Worth.
On a 60-degree day in late March, the church, located on a quiet residential street, had a front stoop featuring three signs: one quoting Martin Luther King Jr., another quoting Pope Francis, and a third welcoming anyone in the community to visit the Still Waters Sensory Room.
Named after the biblical Psalm 23 passage — 'he leads me beside still waters' — the sensory room was converted from an unused confessional. It was designed by Together We Bloom, a Maplewood-based nonprofit that helps make events and spaces more accessible. The room's dark indigo walls match the comfortable chair glider and beanbag, each contributing to the soothing atmosphere. The total cost of the room was under $2,000 and was largely paid for by church funds, plus some donations.
'This sensory room has really changed everything for us,' said Pavitra Makam, a St. Joseph's parishioner and mother of two neurodivergent kids. 'Being able to worship together has been the biggest thing for our family.'
Jay Perkins, who has been in the sensory room business since 2009, said it's often parents in need of a safe, supportive space for their kids who are spearheading the movement to build sensory rooms. When his daughter began exhibiting signs of aggression at age 4, places like libraries (too quiet), playgrounds (too loud) and trampoline parks (too crowded) were inaccessible. That applied to his Episcopal church, too.
'There are so few places where special-needs kids with sensory integration disorders can enjoy it,' said Perkins.
The lack of accessible spaces for his family inspired Perkins to begin building the kinds of rooms his daughter would thrive in. In 2018 he officially launched his company, The Sensory Room, which builds high-end, durable sensory rooms from start to finish and trains people on how to use them.
'It's catching on,' said Perkins, whose company built roughly a dozen rooms in 2022 and 80 in 2023. Though The Sensory Room specializes in schools, Perkin's company has also built rooms for a Broadway theater and an airport, and three in evangelical churches. Most of his custom rooms, he told RNS, start in the $20,000 range.
One of those projects was the $35,000 transformation of a storage room into a state-of-the-art sensory room at Encounter Church, an evangelical congregation about 30 minutes from Dallas. Completed in February 2024, the renovation included interactive tactile and texture panels, bubble tubes, mirrors, new carpet, paint and electrical work, and an LED-star ceiling complete with a digital shooting star. According to the Rev. Chris Binion, who co-founded the church with his wife, Tracy, the decision to create the room was prompted by the Holy Spirit.
'I was in a season of prayer and fasting, and I felt like the Lord asked me how to take care of his 'littles,'' Binion told RNS. He felt God was urging him to support kids with 'diverse needs,'including autism. 'We decided through the direction of the Holy Spirit to say yes, and move forward in this kingdom assignment.'
It's not just churches that are revamping spaces to focus on sensory integration. Temple Emanu-El, a Reform synagogue in Atlanta, has adapted two of its rooms to help folks process sensory input. A former cry room just off the main sanctuary was altered to become the Shalom Sanctuary, a small space with a large window facing the main worship space equipped with fidget toys, beanbags and headphones.
The synagogue also received a $10,000 grant from the Jewish Federation of Greater Atlanta to improve the accessibility of a classroom. That renovation is almost complete, and the room, which features a wall of sensory engagement toys, flexible furniture and alternative seating (think large rubber balls), will be especially helpful for children who need sensory breaks during religious classes or events such as the annual Purim carnival, according to Rabbi Rachael Klein Miller, associate rabbi at the synagogue.
'Something important in Judaism is the idea that we are all created 'b'tzelem Elohim,' in the image of God,' said Klein Miller. 'And much of that is connected to the golden rule of treating people the way we want to be treated and finding space for everybody in the community.'
According to Rebecca Barlow, a regional disability specialist in The Church of Jesus Christ of Latter-day Saints, adding a sensory room to a house of worship doesn't automatically make it accessible to those with sensory needs. 'It's just one piece of a bigger machine that you're trying to build,' said Barlow, disability specialist for the Desert Ridge Stake in Mesa, Arizona.
The first step to building that machine, Barlow said, is asking disabled individuals and their families what it would take to make church feasible for them. When she first became a disability specialist roughly five years ago, feedback was invaluable. 'The biggest thing was listening. The parents of these children know what they need,' said Barlow, who is the parent of a child with autism.
Based on the families' input, she created a sensory room in her meeting house with new donated items. Knowing it would be used by kids who could become aggressive, she removed hard chairs and chalkboard lips that could pose safety risks. She also filled the room with the usual sensory items, added light-blocking curtains and included a night-light that projected a calming light pattern.
Sundays
Kevin Rollason's Sunday newsletter honouring and remembering lives well-lived in Manitoba.
Still, it took more than that to get families back in the door.
'We, as parents of disabled children, often can become jaded, and we lack trust that our children are going to be cared for in a manner appropriate to how special they are,' said Barlow.
To build trust with families, church leaders invited some members of the ward to serve as one-on-one aides for each child with a disability. The aides were trained in the homes of their assigned families and eventually accompanied the kids in the sensory room during church meetings. Barlow also introduced the kids to the sensory room ahead of time via pictures and tours, and ward members, too, received basic training on understanding disabilities and how to use the sensory room.
In the few years since that sensory room opened, the model has gained traction. Barlow says the seven wards in her stake now each have their own disability specialists and sensory rooms, and she routinely takes calls from LDS church members across the country and the globe seeking to set up sensory rooms of their own.
'It feels like we're seeing a cultural shift toward understanding and accepting and integrating people with disabilities,' said Barlow. 'If we want to follow Christ, if we want to emulate him, if we want to be his disciples … they need to be foremost in our mind.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Imfinzi approved in Canada as first and only perioperative immunotherapy for muscle invasive bladder cancer Français
Imfinzi approved in Canada as first and only perioperative immunotherapy for muscle invasive bladder cancer Français

Cision Canada

time11 hours ago

  • Cision Canada

Imfinzi approved in Canada as first and only perioperative immunotherapy for muscle invasive bladder cancer Français

MISSISSAUGA, ON, Aug. 6, 2025 /CNW/ - Health Canada has granted a Notice of Compliance (NOC) for Imfinzi ® (durvalumab) for the treatment of patients with resectable muscle invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by adjuvant Imfinzi monotherapy treatment after radical cystectomy. The approval is based on results from the NIAGARA Phase III trial, which were published in The New England Journal of Medicine. 1, 2 In a planned interim analysis, the Imfinzi-based perioperative regimen demonstrated a statistically significant and clinically meaningful 32% reduction in the risk of disease progression, recurrence, not undergoing surgery, or death versus neoadjuvant chemotherapy with radical cystectomy alone (based on event-free survival [EFS] hazard ratio [HR] of 0.68; 95% confidence interval [CI] 0.56-0.82; p<0.0001). Estimated median EFS was not yet reached for the Imfinzi plus gemcitabine and cisplatin arm versus 46.1 months for the comparator arm. An estimated 67.8% of patients treated with the regimen were event free at two years compared to 59.8% in the comparator arm. 2 Results from the key secondary endpoint of overall survival (OS) showed that the Imfinzi-based perioperative regimen reduced the risk of death by 25% versus the comparator arm (based on OS HR of 0.75; 95% CI 0.59-0.93; p=0.011). Median survival was not yet reached for either arm. An estimated 82.2% of patients treated with the regimen were alive at two years compared to 75.2% in the comparator arm. 2 Imfinzi was generally well tolerated, and no new safety signals were observed in the neoadjuvant and adjuvant settings. The most common adverse events (any Grade, occurring in ≥10% of patients) for the Imfinzi plus chemotherapy arm were nausea (53.6%), fatigue (51.5%), neutropenia (40.4%), anemia (38.7%), constipation (38.7%), decreased appetite (26.6%), rash (20.9%), pyrexia (20.8%), diarrhea (20.6%), abdominal pain (20.2%), vomiting (19.2%), blood creatine increased (18.5%), thrombocytopenia (17.2%), pruritus (15.1%), hypothyroidism (12.6%), neuropathy peripheral (12.5%), leukopenia (10.9%), and aspartate aminotransferase increased (10.4%). 1 "Health Canada's approval of this durvalumab-based perioperative regimen represents a major advance for Canadians with muscle invasive bladder cancer, where nearly half will relapse despite curative treatment," says Dr. Srikala Sridhar, Professor of Medicine at the University of Toronto, Genitourinary Medical Oncologist at the Princess Margaret Cancer Centre and NIAGARA trial investigator. "Findings from the NIAGARA trial showed that this new regimen reduces risk of recurrence and significantly improves survival – which may offer new hope and potential to transform care in this setting." "The high rate of recurrence associated with muscle invasive bladder cancer is an ongoing challenge and source of concern for physicians and patients," says Dr. Normand Blais, Medical Oncologist at the Centre hospitalier de l'Université de Montréal. "The Health Canada approval based on results from the NIAGARA trial may now offer us the opportunity to increase the chance of better patient outcomes and long-term survival by the use of immunotherapy in this setting, which is very good news for patients and their families." Bladder cancer is the 5th most common cancer in Canada, with more than 13,000 patients diagnosed each year. 3 The most common type of bladder cancer is urothelial carcinoma, which begins in the urothelial cells of the urinary tract. Bladder cancer is considered muscle invasive when there is evidence of the tumour invading the muscle wall of the bladder but no distant metastases. 4 In MIBC, approximately 50% of patients who undergo bladder removal surgery experience disease recurrence. 5 Treatment options that prevent disease recurrence after surgery are critically needed in this curative-intent setting. "This decision by Health Canada represents an important step forward for all Canadians affected by muscle invasive bladder cancer," says Michelle Colero, Executive Director, Bladder Cancer Canada. "For many patients and families, the fear of recurrence after surgery has been overwhelming. This new treatment option may offer renewed hope for longer, healthier lives." About NIAGARA 2 NIAGARA is a randomized, open-label, multi-centre, global Phase III trial evaluating perioperative Imfinzi as treatment for patients with MIBC before and after radical cystectomy. In the trial, 1,063 patients were randomized to receive four cycles of Imfinzi plus neoadjuvant chemotherapy prior to cystectomy followed by eight cycles of Imfinzi monotherapy, or neoadjuvant chemotherapy alone prior to cystectomy with no further treatment after surgery. NIAGARA is the largest global Phase III trial in this setting to date. The trial is being conducted at 192 centres in 22 countries across North America (including Canada), South America, Europe, Australia and Asia. Its dual primary endpoints are EFS and pathologic complete response at the time of cystectomy. Key secondary endpoints are OS and safety. About Imfinzi Imfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80 proteins, countering the tumour's immune-evading tactics and releasing the inhibition of immune responses. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical business whose innovative medicines are used by millions of patients worldwide. The company's core areas of scientific focus are Oncology; Cardiovascular, Renal and Metabolic (CVRM); Rare Disease; Respiratory & Immunology; and Vaccine & Immune Therapies. In Canada, the company employs more than 2,400 people and recently announced a major expansion of its research footprint in Mississauga – including the expansion of its AstraZeneca R&D Hub and the creation of a new Alexion Development Hub for Rare Diseases. AstraZeneca was recently recognized as one of Canada's Top 100 Employers, one of Canada's Most Admired Corporate Cultures, and a Greater Toronto Top Employer. AstraZeneca is committed to contributing to a more sustainable future for people, society and planet taking important steps to help tackle some of the most pressing sustainability challenges globally – from climate and biodiversity loss, to health equity and health system resilience. AstraZeneca was one of the first seven companies globally to have its net zero targets verified by the Science-Based Targets initiative (SBTi) Corporate Net-Zero Standard. For more information, please visit the company's website at Imfinzi ® and the AstraZeneca logo are registered trademarks of AstraZeneca AB, used under license by AstraZeneca Canada Inc. SOURCE AstraZeneca Canada Inc.

MaRS and Toyota Mobility Foundation select participants for the Mobility Unlimited Hub's second cohort
MaRS and Toyota Mobility Foundation select participants for the Mobility Unlimited Hub's second cohort

Cision Canada

time11 hours ago

  • Cision Canada

MaRS and Toyota Mobility Foundation select participants for the Mobility Unlimited Hub's second cohort

These 10 high-potential startups are working on affordable prosthetics, smart exoskeletons and other innovative solutions to support active mobility. TORONTO, Aug. 6, 2025 /CNW/ - MaRS Discovery District and the Toyota Mobility Foundation (TMF) today announced the 10 high-potential startups that will be participating in the second cohort of the Mobility Unlimited Hub (MUH) in Toronto. These companies bring novel technological approaches to active mobility and transformational devices and will leverage the Hub's network to accelerate the commercialization of their solutions in both Canada and globally. Building on the success of the first cohort, this program is once again focused on active mobility, including rehabilitative, adaptive and assistive solutions, with the aim of fostering a more inclusive and accessible society. The human-centered philosophy behind the MUH is simple: When people are free to move, they can fully realize their potential. The power of the ecosystem The MUH was launched in Toronto in 2024, in response to a clear need. According to a recent Canadian Survey on Disability, 27 percent of Canadians aged 15 years and older — eight million people — have one or more disabilities that limit their daily activities. Additionally, 30 percent of people living with disabilities in Canada report that their requirements for assistive devices have not been fulfilled. After receiving more than 70 applications from across the globe, MaRS and TMF, along with their advisory committee, have selected 10 innovative startups to participate in the second cohort. The new MUH cohort members include: Bionic Power Inc. - This Vancouver-based startup has developed a smart orthosis to address knee-related gait deficiencies, allowing people with cerebral palsy, spina bifida and post-polio syndrome to move more easily, safely and independently. GiveVision - This London, U.K. startup has developed sight-enhancing wearable headsets that allow visually impaired users to watch live sports and cultural events. Human in Motion Robotics Inc. - This Vancouver-based startup has developed a wearable self-balancing lower‑limb exoskeleton designed for rehabilitation and personal mobility. ImaginAble Solutions Inc. - This Hamilton-based startup has developed an assistive device to help people with limited hand mobility write, draw, paint and use touchscreens. Kinesix XR Inc. - This Montreal- and Chile-based startup leverages virtual reality and augmented reality technologies to deliver AI-powered rehabilitation therapy for patients recovering from strokes and traumatic brain injuries and those living with Parkinson's disease, multiple sclerosis (MS), chronic pain and other ongoing conditions. Ora Medical Inc. - This Montreal-based startup has developed a hands-free gait trainer designed to support walking rehabilitation for children with mobility challenges. Possibility Neurotechnologies - This Calgary-based startup has developed a mobile app that transforms EEG headsets into brain-computer interfaces, allowing users to control devices and communicate using only their thoughts. smartARM Robotics Inc. - This Toronto-based startup has developed an intuitive, affordable, AI-powered bionic arm with vision-based grip recognition. Steadiwear - This Toronto-based startup has developed hand-stabilization gloves to assist adults with tremors, including those caused by Parkinson's disease and strokes. Victoria Hand Project - This Victoria-based non-profit partners with local clinics to manufacture 3D-printed upper-limb prosthetics for amputees in low-resource and conflict-affected regions. "Mobility means moving forward with new ideas. Our first cohort proved the power of the community to scale new active mobility solutions faster and more effectively, and bring needed change to the industry," says William Chernicoff, program manager at Toyota Mobility Foundation. "Founded on a commitment to human-centred design, the Hub was created to position this market as one worth investing in, and we are seeing that transformation. There remains a wide range of unmet needs and challenges that limit active mobility, which is why we are expanding the next cohort's scope to allow for more diversity in the problems the startups are seeking to solve." Critical to the MUH's success is the ongoing commitment from MaRS Discovery District, which includes expanded access to state-of-the-art working spaces at the MaRS Centre in downtown Toronto. This highly effective collaboration demonstrates that change can happen rapidly in the context of a holistic ecosystem designed to drive innovation in active mobility. "The Mobility Unlimited Hub is more than a program — it's a powerful example of what happens when innovation is driven by purpose," says Morgan Lorimer, senior manager of cohort programs in innovation ecosystems at MaRS. "With a new dedicated co-working space at the MaRS Centre, we're creating the environment these startups need to scale, turning bold ideas into inclusive mobility solutions that improve lives and expand access." "Joining this cohort is a game changer for ImaginAble Solutions as we enter our next phase of growth, scaling Guided Hands® to reach more children and adults with hand disabilities around the world," says Lianna Genovese, CEO and founder of ImaginAble Solutions Inc., part of the new MUH cohort. "Access to industry experts in manufacturing and research will accelerate our ability to expand into schools, hospitals, and homes." Entrepreneurs speed toward scalability The first cohort's successes far exceeded the initial expectations held by both participants and program organizers, demonstrating that the path from early-stage innovation to market scale can be accelerated with the right combination of resources. Those resources include marketing and public relations support, funding opportunities, regulatory advice and guidance to improve manufacturing efficiency and supply chain optimization. "The Mobility Unlimited Hub has been instrumental in accelerating our growth. The opportunity to collaborate with others in the mobility space has enhanced our production capabilities and streamlined our business processes, ultimately delivering a better experience for our customers," says Eugene Cherny, CEO and co-founder of Cheelcare, a member of the inaugural MUH cohort. Since the inception of this program, startup members have hit key milestones. Highlights include: More than $8.1 million in funding secured across the cohort. AWL-Electricity established a partnership with Infineon Technologies, Germany's largest semiconductor manufacturer, gaining a global distribution partner to revolutionize wireless power transmission. Axtion Independence Mobility secured agreements with distribution partners across Canada, the European Union, United Kingdom and the United States, facilitating the venture's entry into the market in the fall of 2025. Braze Mobility Inc. received two patents, helping the company expand into Europe and scale in the U.S. Cheelcare raised $3.5 million and is now publicly listed on the TSX Venture Exchange following its reverse takeover of Departure Bay Capital Corp. Deaf AI secured multi-year R&D funding from Transport Canada, NSERC and Mitacs, in partnership with top academic institutions, including the University of British Columbia, Toronto Metropolitan University and Sheridan College. Trexo Robotics Inc. users have taken more than 100 million steps — a giant leap in the company's mission to help children with mobility challenges gain independence. Visit the Mobility Unlimited Hub web page for more information about the program. About Toyota Mobility Foundation The Toyota Mobility Foundation (TMF) was established in August 2014 by the Toyota Motor Corporation (TMC) to support the development of a more mobile society in which everyone can move freely. The Foundation underscores TMC's ongoing commitment to continuous improvement and respect for people. It utilizes Toyota's expertise and technologies to support strong mobility systems while eliminating disparities in mobility. TMF works in partnership with universities, governments, non-profits, research institutions and other organizations, creating programs that are aligned with the UN Sustainable Development Goals (SDGs) to address mobility issues around the world. About MaRS Discovery District MaRS Discovery District is a charitable organization and North America's largest urban innovation hub dedicated to helping Canadian technology companies succeed. With a focus on climate, health sciences and other emerging technologies, MaRS supports startups tackling some of the world's most pressing issues. MaRS spans more than 1.5 million square feet of cutting-edge office, lab, meeting and event space in downtown Toronto. MaRS has helped ventures generate $11.5 billion in cumulative revenue, raise $19 billion in funding, and create and maintain more than 33,000 jobs. The MaRS platform also includes MaRS IAF, one of Canada's top seed-stage venture funds. Through its world-class facilities, strategic programs and partnerships, MaRS accelerates the adoption of groundbreaking Canadian technology and bolsters a globally competitive innovation ecosystem.

Some southern Manitoba households ignored public health measles directives, documents reveal
Some southern Manitoba households ignored public health measles directives, documents reveal

Winnipeg Free Press

timea day ago

  • Winnipeg Free Press

Some southern Manitoba households ignored public health measles directives, documents reveal

Public health officials are up against brazen rebellion as they tackle a recent resurgence in measles. Newly released government documents shed light on the challenges related to limiting the spread of the highly infectious disease in Manitoba. Southern Health-Santé Sud has advised that area households are ignoring public health directives, as per a series of May briefings obtained by the Free Press via a freedom of information request. 'Some affected families are allowing their unimmunized, asymptomatic children who are household contacts to cases to attend school,' they each state. Seven public schools — elementary buildings in Gretna, Dugald, Plum Coulee, Grunthal (Green Valley School) and Schanzenfeld (both Prairie Dale and Southwood schools), as well as Lorette Collegiate, a Grades 9-12 school just south of Winnipeg — were exposure sites in the spring. Three others were alerted about measles activity due to overlapping school bus routes. A Winnipeg-based home school was also affected by a positive case. Unvaccinated close contacts are supposed to isolate for up to 21 days. Bioethicist Arthur Schafer said vaccine hesitancy was 'aggravated' by COVID-19 pandemic-related backlash against public health mandates and misinformation lumping all shots together. 'Whatever they think of the COVID vaccine, the measles, mumps, rubella vaccine is proven safe and effective and it really is a moral obligation of parents to protect our children and to protect the community,' said the founding director of the University of Manitoba's Centre for Professional and Applied Ethics. The rate of children who have received the MMR vaccine, which has proven to be about 97 per cent effective, is trending downwards in Manitoba. The latest available uptake data shows 65 per cent of seven-year-olds had MMR coverage in 2023. That figure was 74 per cent in 2020, the same as it was a decade ago. Schafer noted the few individuals who do contract the virus despite being immunized almost always have milder symptoms and are less infectious. As far as he is concerned, the province is overdue for launching a public health campaign that touts the effectiveness of the MMR vaccine. A total of 165 confirmed patients with measles — for which there is no cure — have been identified in Manitoba since the start of 2025. There were 10 additional 'probable' cases at the end of July. Health Minister Uzoma Asagwara said it's troubling whenever residents ignore public health guidance, providing evidence that more work is required on the part of the province. 'We are in an era of misinformation and disinformation and we have to work really hard to make sure that people have accurate, science-based information to make the most informed health decisions for themselves and their families,' Asagwara said. The public service informed the minister's office in a June 2 measles update that it had identified an event in southern Manitoba with 'high potential' to be a super-spreader situation. 'Public Health is monitoring but does not anticipate significant co-operation from the group on contacts of the case,' the internal briefing said. Asagwara, a former nurse, said public health officials are already doing outreach to build trust with families and distributing educational materials on vaccines. Letters outlining the current outbreak and tips to protect families have been written in English, French and Low German. In the wake of reports that close contacts were flouting isolation requirements, Southern Health-Santé Sud drafted a reminder to improve compliance in the region. The followup advised recipients about the severity of measles, particularly for high-risk patients, and urged them to protect their communities. Most patients recover from measles within several weeks, but an infection can lead to an ear infection, pneumonia, seizures, brain damage or death. The disease is particularly deadly for children. Wednesdays A weekly dispatch from the head of the Free Press newsroom. Manitoba's largest hospital began actively screening visitors for measles, which typically presents as a red, blotchy rash, earlier this summer. Signage has also been posted across the Health Sciences Centre campus. The extra step is taking place via intercom and at reception desks inside the women's and children's hospitals, neonatal intensive care unit and outpatient clinics, among other sites. Asked about those changes, which went into effect on July 7, a spokesperson for Doctors Manitoba said they should be treated as 'a wake-up call for Manitobans.' – With files from Malak Abas Maggie MacintoshEducation reporter Maggie Macintosh reports on education for the Free Press. Originally from Hamilton, Ont., she first reported for the Free Press in 2017. Read more about Maggie. Funding for the Free Press education reporter comes from the Government of Canada through the Local Journalism Initiative. Every piece of reporting Maggie produces is reviewed by an editing team before it is posted online or published in print — part of the Free Press's tradition, since 1872, of producing reliable independent journalism. Read more about Free Press's history and mandate, and learn how our newsroom operates. Our newsroom depends on a growing audience of readers to power our journalism. If you are not a paid reader, please consider becoming a subscriber. Our newsroom depends on its audience of readers to power our journalism. Thank you for your support.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store